Patent Royalties

A patent royalty is a payment made by a licensee to a patent holder in exchange for the right to use a patented invention. It is the price of permission — the economic consideration that flows from the licensee to the patent holder in return for being allowed to make, use, sell, or import products covered by the patent. Royalties can be structured in several ways: as a percentage of net sales (running royalty, the most common structure), as a one-time lump sum for a fully paid-up license, as minimum annual payments guaranteeing the patent holder a floor of income, as milestone payments triggered by specific commercial or regulatory events, or as a royalty-free license (common in cross-license arrangements where each party gives the other access without cash payment). Royalties are governed by the license agreement between the parties, which specifies the royalty base (net sales, units sold, revenue), the royalty rate, the payment schedule, audit rights, and the consequences of underpayment. In patent infringement litigation, the 'reasonable royalty' is the floor for damages under 35 U.S.C. § 284 — even if the patent holder cannot prove lost profits, they are entitled to at least the royalty that a hypothetical willing licensor and willing licensee would have agreed to at the time infringement began. This reasonable royalty standard is the primary damages metric in most patent cases today.

The reasonable royalty is calculated using the 'hypothetical negotiation' framework established in Georgia-Pacific Corp. v. U.S. Plywood Corp. (S.D.N.Y. 1970). Courts ask: what royalty rate would a willing licensor and willing licensee have agreed to in a hypothetical arms-length negotiation just before infringement began, with both parties knowing the patent is valid and infringed and both wanting to complete a deal? The 15 Georgia-Pacific factors guide this inquiry (see the factor list in this guide). The factors most heavily weighted in modern practice are: (1) Comparable licenses — what royalty rates have actually been paid for this patent or substantially similar patents is the most direct evidence of market value; expert witnesses construct 'comparable license' analyses as the centerpiece of damages expert reports. (2) The royalty base — the 'Entire Market Value Rule' (EMVR) allows royalties to be computed on the entire product revenue only when the patent is the basis for consumer demand; courts have pushed toward using a royalty base limited to the 'smallest saleable patent-practicing unit' (SSPPU) to avoid inflating damages by multiplying a small rate against a huge revenue base. (3) Apportionment — the court must apportion the royalty to reflect only the value of the patented feature, not the entire product; in multi-component products, this often requires complex expert analysis. Modern practice also draws on the Nash Bargaining Solution (splitting the incremental profit from the patented feature 50/50 between licensor and licensee as an economic benchmark) and on the book of wisdom (post-negotiation evidence of actual commercial performance can inform but not retroactively set the hypothetical negotiation rate).

Royalty stacking occurs when multiple patents are each essential to implementing a product or standard, and each patent holder demands a royalty based on the product's full value. If 100 different patent holders each demand 2% of smartphone revenue because their patent is 'essential,' the total royalty burden would exceed 200% of revenue — obviously unworkable. Royalty stacking is a serious practical and legal problem in industries with highly fragmented patent ownership (consumer electronics, mobile communications, Wi-Fi, video codecs). It is the central economic argument behind FRAND licensing for standard-essential patents: because standards necessarily involve hundreds of patents owned by dozens of companies, any individual patent holder claiming a royalty based on the full value of the standard would make implementation economically impossible. Courts and competition authorities have responded by: (1) Requiring royalties to be based on the Smallest Saleable Patent-Practicing Unit (SSPPU) rather than the entire product value — a patent covering a Wi-Fi chip feature should be based on chip revenue, not smartphone revenue. (2) Applying top-down FRAND royalty analysis: estimate the total acceptable royalty for all SEPs in a standard combined (e.g., 10% of device price), then calculate each patent holder's share proportional to their contribution. (3) Patent pools that aggregate royalties and set a single license rate for the pool, eliminating stacking among pool members. For non-SEP patents, stacking remains largely unregulated — each patent holder can demand what the market will bear — but buyers and licensees increasingly negotiate portfolio licenses covering entire technology areas to eliminate stacking risk.

FRAND (Fair, Reasonable, and Non-Discriminatory) describes the licensing obligation that holders of standard-essential patents (SEPs) typically undertake when contributing technology to industry standards bodies. A patent is 'standard-essential' if it is technically necessary to implement a standard — no standard-compliant product can be built without practicing the patent. When a patent holder declares a patent essential and commits to FRAND licensing, it agrees to license on terms that are: Fair — reasonable given the contributions to the standard; Reasonable — economically workable for licensees and reflective of the patent's actual technical contribution; Non-Discriminatory — similarly situated licensees get similarly priced licenses (so a dominant company cannot get better terms than a startup for the same rights). If parties cannot agree on FRAND terms, courts set a FRAND rate. Major FRAND cases have established methodologies: comparable licenses (what has this patent actually been licensed for in arm's-length transactions?), top-down analysis (aggregate acceptable SEP royalty for the standard ÷ number/weight of essential patents), and adjusted Nash Bargaining. UK courts (Unwired Planet v. Huawei; Optis v. Apple), U.S. courts (Microsoft v. Motorola; TCL v. Ericsson; InterDigital v. Lenovo), and the ECJ (Huawei v. ZTE) have each developed their own frameworks. Key disputes in FRAND: the appropriate royalty base (chip vs. device); whether comparable licenses must include 'comparable' or just 'substantially similar' rights; whether portfolio rates can be extrapolated to individual patents; and how to value declared-essential patents that are 'over-declared' (not actually essential, despite declaration).

For non-SEP patents (the vast majority of patents), a patent holder can in theory charge any royalty rate a willing licensee will accept — patent law does not set a ceiling. If a company's patent is the key component of a highly valuable product and there is no design-around, the patent holder can demand a high royalty. In practice, market forces and litigation risk constrain rates: (1) Licensees will refuse or design around if rates are economically unworkable; (2) Courts cap damages at a 'reasonable royalty' based on hypothetical negotiation — not the patent holder's wish list; (3) Antitrust law prohibits certain patent licensing conduct even for valid patents, including tying (conditioning a license on purchasing something else) and price-fixing through license terms in some contexts. For SEP patents, FRAND obligations limit the royalty. If a SEP holder demands a non-FRAND rate, a potential licensee who has complied with Huawei v. ZTE procedures (EU) or who is otherwise 'willing' can: (1) Sue for breach of the FRAND commitment and seek a court-set FRAND rate; (2) Use the demand as evidence of misuse or antitrust violation; (3) In some jurisdictions, seek an injunction on the SEP holder's injunction (i.e., the SEP holder may be blocked from getting an injunction while FRAND negotiations are pending). The 2023 EC regulation proposed on SEPs would add an additional layer of essentiality checks and FRAND rate determinations by a central authority — still in legislative process as of 2024.